Pembrolizumab
Active Ingredients
pembrolizumab
Drug Classes
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Top Side Effects of Pembrolizumab
abdominal painappetite decreasedawkwardnessback painback painblack stoolsbladder painbleeding from gumsblistering of skinbloating of armsbloating of facebloating of feetbloating of handsbloating of lower legsbloody diarrheabloody urineblue fingernailsblue lipsblue skinblurred visionbody achebone painbruisingburning during urinationburning feelingchanges in moodchest painchillsclay-colored stoolscloudy urinecold feelingconfusioncongestion of the earconstipationconvulsionscoughcracking of skincramping of the stomachcreamy white patches in mouthdark brown urine
Top Conditions of Pembrolizumab
MelanomaOvarian CancerNon Small Cell Lung CancerPancreatic CancerProstate CancerStomach CancerRenal Cell CarcinomaHeart FailureMyasthenia GravisMultiple MyelomaSmall Cell Lung CancerHyponatremiaUrothelial CarcinomaBullous PemphigoidBiliary Tract TumorDiffuse Large B-Cell LymphomaThyroid CancerPsoriasisOsteosarcomaUveitisGastric CancerAdrenal InsufficiencyImmunosuppressionPancreatitisBreast CancerBladder CancerEndometrial CancerCervical CancerHead and Neck CancerColorectal CancerBreast Cancer, MetastaticDermatomyositisRenal FailureSoft Tissue SarcomaEncephalopathyFatigueCholangiocarcinomaSkin RashMerkel Cell CarcinomaSquamous Cell CarcinomaNasopharyngeal CarcinomaHepatocellular CarcinomaMultiple SclerosisHyperthyroidismExtravasationHemolytic AnemiaBasal Cell CarcinomaUveal MelanomaBreast Cancer, AdjuvantVitiligo